FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention describes the novel compounds of the general formula (I) where values R1-R5,R14, Q, n are given in p. 1 of the invention claim. Compounds show the selective activity with respect to specific receptors of retinoic acid. They can be used for treatment of patients with different pathological states. Invention describes also pharmaceutical composition based on compounds of the formula (I) and the method of SUPPRESSION of pathological states and the method of modulation of processes (variants). EFFECT: valuable properties of new compounds. 26 cl, 12 dwg, 51 ex
Title |
Year |
Author |
Number |
BIAROMATIC COMPOUNDS AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON THEREOF |
1998 |
- Bernardon Zhan-Mishel'
- Diaz Filipp
|
RU2185373C2 |
PHARMACEUTICAL COMPOSITION |
1995 |
- Serzh Mishel'
- Kristin Katelino
- Mari-Sesil' Lenuar-Vial'
- Mishel' Demarshez
|
RU2120304C1 |
BICYCLE AROMATIC COMPOUNDS AND COMPOSITION BASED ON THEREOF |
1999 |
|
RU2188190C2 |
PROPINYL-DIAROMATIC COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON THEREOF |
1994 |
- Zhan-Mishel' Bernardon[Fr]
|
RU2111204C1 |
NOVEL RETINOIDS FOR EMPHYSEMA TREATMENT |
2001 |
- Lap'Er Zhan-Mark
- Rotstehjn Dehjvid Mark
- Sjogren Ehrik Brajan
|
RU2282616C2 |
BICYCLIC AROMATIC COMPOUNDS AND PHARMACEUTICAL AND COSMETIC COMPOSITION CONTAINING THEREOF |
1995 |
|
RU2141471C1 |
RETINOID COMPOUNDS (VARIANTS), COMPOSITION, METHOD FOR ASSAY OF RETINOID HORMONE ANTAGONISTS, METHOD OF TREATMENT AND INTERMEDIATE SUBSTANCES |
1996 |
- Klejn Ehlliott S.
- Dzhonson Alan T.
- Stehndiven Ehndrju M.
- Biard Richard L.
- Gillett Sehmjuel Dzh.
- Duong Tien T.
- Nehgpehl Sanil
- Valigonda Vid'Jasagar
- Teng Min
- Chandraratna Roshanta A.
|
RU2203884C2 |
ARYL- OR HETEROARYLAMIDES OF TETRAHYDRONAPHTHALENE-, CHROMAN-, THIOCHROMAN- AND 1,2,3,4-TETRAHYDROQUINOLINE CARBOXYLIC ACIDS SHOWING RETINOID-LIKE BIOLOGICAL ACTIVITY |
1996 |
- Teng Min
- Duong Tien T.
- Chandraratna Roshanta A.
|
RU2163906C2 |
METHODS OF THERAPY BY APPLYING THE COMPOUNDS EITHER OF SPECIFIC OR SELECTIVE ACTIVITY TO RETINAL ACID RECEPTOR RAR |
1996 |
- Teng Min
- Duong Tien T.
- Chandraratna Roshanta A.
|
RU2191009C2 |
APPLICATION OF AGONIST-LIGAND SPECIFIC FOR RAR-γ,-TYPE RECEPTORS FOR APOPTOSIS RATE INCREASE |
1996 |
- Feshush Laslo
- Sondi Zhuzha
- Rajkhert Uve
|
RU2188037C2 |